These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 25896763)
21. VEGF regulates TRPC6 channels in podocytes. Thilo F; Liu Y; Loddenkemper C; Schuelein R; Schmidt A; Yan Z; Zhu Z; Zakrzewicz A; Gollasch M; Tepel M Nephrol Dial Transplant; 2012 Mar; 27(3):921-9. PubMed ID: 21868397 [TBL] [Abstract][Full Text] [Related]
22. The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis. Zhang HT; Wang WW; Ren LH; Zhao XX; Wang ZH; Zhuang DL; Bai YN Cell Physiol Biochem; 2016; 40(5):1079-1093. PubMed ID: 27960162 [TBL] [Abstract][Full Text] [Related]
23. Transient receptor potential channel 6 knockdown prevents apoptosis of renal tubular epithelial cells upon oxidative stress via autophagy activation. Hou X; Xiao H; Zhang Y; Zeng X; Huang M; Chen X; Birnbaumer L; Liao Y Cell Death Dis; 2018 Oct; 9(10):1015. PubMed ID: 30282964 [TBL] [Abstract][Full Text] [Related]
24. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Ilatovskaya DV; Staruschenko A Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930 [TBL] [Abstract][Full Text] [Related]
25. TRPC6-Mediated Ca2+ Signaling is Required for Hypoxia-Induced Autophagy in Human Podocytes. Ji T; Zhang C; Ma L; Wang Q; Zou L; Meng K; Zhang R; Jiao J Cell Physiol Biochem; 2018; 48(4):1782-1792. PubMed ID: 30078002 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms underlying modulation of podocyte TRPC6 channels by suPAR: Role of NADPH oxidases and Src family tyrosine kinases. Kim EY; Hassanzadeh Khayyat N; Dryer SE Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3527-3536. PubMed ID: 30293571 [TBL] [Abstract][Full Text] [Related]
27. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury. Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of TRPC6 by protein kinase C isoforms in cultured human podocytes. Ambrus L; Oláh A; Oláh T; Balla G; Saleem MA; Orosz P; Zsuga J; Bíró K; Csernoch L; Bíró T; Szabó T J Cell Mol Med; 2015 Dec; 19(12):2771-9. PubMed ID: 26404773 [TBL] [Abstract][Full Text] [Related]
29. Losartan treating podocyte injury induced by Ang II via downregulation of TRPC6 in podocytes. Chi-Xianggeng ; Hu-Bo ; Yu SY; Yin-Lianghong ; Meng-Yu ; Wang-Boxun ; Yang-Jinsheng ; Lin-Jiahui ; Huang-Dexu ; Chen-Lanlan J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1118-24. PubMed ID: 25795457 [TBL] [Abstract][Full Text] [Related]
30. Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca2+ and RhoA activation. Jiang L; Ding J; Tsai H; Li L; Feng Q; Miao J; Fan Q Exp Biol Med (Maywood); 2011 Feb; 236(2):184-93. PubMed ID: 21321315 [TBL] [Abstract][Full Text] [Related]
31. TGF-β1 induces podocyte injury through Smad3-ERK-NF-κB pathway and Fyn-dependent TRPC6 phosphorylation. Yu L; Lin Q; Liao H; Feng J; Dong X; Ye J Cell Physiol Biochem; 2010; 26(6):869-78. PubMed ID: 21220918 [TBL] [Abstract][Full Text] [Related]
32. Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology. Ma R; Chaudhari S; Li W Antioxid Redox Signal; 2016 Nov; 25(13):732-748. PubMed ID: 26937558 [TBL] [Abstract][Full Text] [Related]
33. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease. Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506 [TBL] [Abstract][Full Text] [Related]
34. Atractylodin inhibits fructose-induced human podocyte hypermotility via anti-oxidant to down-regulate TRPC6/p-CaMK4 signaling. Chen L; Tang YL; Liu ZH; Pan Y; Jiao RQ; Kong LD Eur J Pharmacol; 2021 Dec; 913():174616. PubMed ID: 34780752 [TBL] [Abstract][Full Text] [Related]
35. Insulin increases filtration barrier permeability via TRPC6-dependent activation of PKGIα signaling pathways. Rogacka D; Audzeyenka I; Rachubik P; Rychłowski M; Kasztan M; Jankowski M; Angielski S; Piwkowska A Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1312-1325. PubMed ID: 28263796 [TBL] [Abstract][Full Text] [Related]
36. The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis. Chen Y; Lin L; Tao X; Song Y; Cui J; Wan J BMC Nephrol; 2019 Mar; 20(1):106. PubMed ID: 30922260 [TBL] [Abstract][Full Text] [Related]
37. Influence of tacrolimus on podocyte injury inducted by angiotensin II. Shengyou Y; Li Y; Zhihong H; Yuanyuan M J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):260-6. PubMed ID: 25650384 [TBL] [Abstract][Full Text] [Related]
38. Acute ethanol induces apoptosis by stimulating TRPC6 via elevation of superoxide in oxygenated podocytes. Lu XY; Liu BC; Wang LH; Yang LL; Bao Q; Zhai YJ; Alli AA; Thai TL; Eaton DC; Wang WZ; Ma HP Biochim Biophys Acta; 2015 May; 1853(5):965-74. PubMed ID: 25601712 [TBL] [Abstract][Full Text] [Related]
40. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6. Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]